GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medeon Biodesign Inc (ROCO:6499) » Definitions » Institutional Ownership

Medeon Biodesign (ROCO:6499) Institutional Ownership : 0.36% (As of Sep. 22, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Medeon Biodesign Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medeon Biodesign's institutional ownership is 0.36%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medeon Biodesign's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medeon Biodesign's Float Percentage Of Total Shares Outstanding is 0.00%.


Medeon Biodesign Institutional Ownership Historical Data

The historical data trend for Medeon Biodesign's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medeon Biodesign Institutional Ownership Chart

Medeon Biodesign Historical Data

The historical data trend for Medeon Biodesign can be seen below:

2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31
Institutional Ownership 0.22 0.24 0.28 0.31 0.32 0.33 0.36 0.36 0.36 0.36

Medeon Biodesign Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Medeon Biodesign Business Description

Traded in Other Exchanges
N/A
Address
No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.

Medeon Biodesign Headlines

No Headlines